The characterization of preclinical evidence for agents entering clinical development
The translation of basic biological discoveries into clinical applications that improve human health remains a slow, expensive, and failure-prone endeavor despite tremendous advances in genetics and molecular biology. Drug development failures have immense costs, including the burden of subjecting p...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en |
| Published: |
McGill University
2013
|
| Subjects: | |
| Online Access: | http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=117175 |